Codiak BioSciences (CDAK)

Codiak BioSciences (CDAK) Stock Price & Analysis


CDAK Stock Chart & Stats

Day’s Range$0.05 - $0.11
52-Week Range― - ―
Previous Close$0.13
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding36,829,626
10 Day Avg. Volume2,256,999
30 Day Avg. Volume805,900
Standard Deviation0.42
Financial Highlights & Ratios
Price to Book (P/B)0.42
Price to Sales (P/S)0.27
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Codiak BioSciences’s price range in the past 12 months?
Currently, no data Available
What is Codiak BioSciences’s market cap?
Currently, no data Available
When is Codiak BioSciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Codiak BioSciences’s earnings last quarter?
Currently, no data Available
Is Codiak BioSciences overvalued?
According to Wall Street analysts Codiak BioSciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Codiak BioSciences pay dividends?
    Codiak BioSciences does not currently pay dividends.
    What is Codiak BioSciences’s EPS estimate?
    Codiak BioSciences’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Codiak BioSciences have?
    Currently, no data Available
    What happened to Codiak BioSciences’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Codiak BioSciences?
    Among the largest hedge funds holding Codiak BioSciences’s share is Flagship Pioneering Inc.. It holds Codiak BioSciences’s shares valued at 1M.


      Codiak BioSciences Stock Smart Score

      This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
      Learn more about TipRanks Smart Score

      Company Description

      Codiak BioSciences

      Codiak BioSciences Inc is a development-stage biopharmaceutical company focused on the development of exosome-based therapeutics aimed at treating a broad range of diseases, including oncology, neuro-oncology, neurology, neuromuscular disease, infectious disease and rare disease.


      Top 5 ETFs holding CDAK

      Market Value
      Smart Score
      Vanguard Total Stock Market ETF
      Up to five ETFs with an Outperform Smart Score that hold CDAK. The ETFs are listed according to market value of CDAK within the ETF


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      Quince Therapeutics
      CASI Pharmaceuticals
      Spruce Biosciences

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis